Literature DB >> 28914645

Notch inhibitors and their role in the treatment of triple negative breast cancer: promises and failures.

Marzia Locatelli1, Giuseppe Curigliano.   

Abstract

PURPOSE OF REVIEW: Notch signaling is a highly evolutionarily conserved cell-to-cell communication system that is involved in a number of pivotal cellular processes, such as development, stem cell maintenance, cell fate specification, differentiation, proliferation, and death. Much progress has been made in understanding Notch signaling. This review will focus on the role of canonical Notch signaling pathway in breast cancer cause and progressing. RECENT
FINDINGS: In this review, we will discuss the results of the studies using drugs, which target the Notch pathway.
SUMMARY: Notch sustains a proliferative signaling and protects from apoptosis, favors the angiogenic switch, the chemoresistance and radioresistance, controls the cancer stemness, and induces a prometastatic phenotype. Therefore, Notch-signaling represented an interesting target in the strategy against cancer growth.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28914645     DOI: 10.1097/CCO.0000000000000406

Source DB:  PubMed          Journal:  Curr Opin Oncol        ISSN: 1040-8746            Impact factor:   3.645


  9 in total

1.  Dual targeting of Notch and Wnt/β-catenin pathways: Potential approach in triple-negative breast cancer treatment.

Authors:  Fatma Nasser; Nermine Moussa; Maged W Helmy; Medhat Haroun
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2020-10-14       Impact factor: 3.000

2.  Mismatch repair deficiency and aberrations in the Notch and Hedgehog pathways are of prognostic value in patients with endometrial cancer.

Authors:  Genovefa Polychronidou; Vassiliki Kotoula; Kyriaki Manousou; Ioannis Kostopoulos; Georgia Karayannopoulou; Eleni Vrettou; Mattheos Bobos; Georgia Raptou; Ioannis Efstratiou; Dimitrios Dionysopoulos; Kyriakos Chatzopoulos; Sotirios Lakis; Sofia Chrisafi; Dimitrios Tsolakidis; Alexios Papanikolaou; Nikolaos Dombros; George Fountzilas
Journal:  PLoS One       Date:  2018-12-06       Impact factor: 3.240

Review 3.  Eribulin in Triple Negative Metastatic Breast Cancer: Critic Interpretation of Current Evidence and Projection for Future Scenarios.

Authors:  Laura Pizzuti; Eriseld Krasniqi; Giacomo Barchiesi; Marco Mazzotta; Maddalena Barba; Antonella Amodio; Gioia Massimiani; Fabio Pelle; Ramy Kayal; Enrico Vizza; Antonino Grassadonia; Silverio Tomao; Aldo Venuti; Teresa Gamucci; Paolo Marchetti; Clara Natoli; Giuseppe Sanguineti; Gennaro Ciliberto; Patrizia Vici
Journal:  J Cancer       Date:  2019-10-12       Impact factor: 4.207

Review 4.  Self-Renewal Signalling Pathway Inhibitors: Perspectives on Therapeutic Approaches for Cancer Stem Cells.

Authors:  Qingyun Zhu; Yingying Shen; Xiguang Chen; Jun He; Jianghua Liu; Xuyu Zu
Journal:  Onco Targets Ther       Date:  2020-01-16       Impact factor: 4.147

5.  ADAM10 is involved in the oncogenic process and chemo-resistance of triple-negative breast cancer via regulating Notch1 signaling pathway, CD44 and PrPc.

Authors:  Yuanyuan Cheng; Lishuang Lin; Xiaoyan Li; Aiqi Lu; Chenjian Hou; Qian Wu; Xiaomu Hu; Zhongwen Zhou; Zhongqing Chen; Feng Tang
Journal:  Cancer Cell Int       Date:  2021-01-07       Impact factor: 5.722

6.  GASC1 promotes glioma progression by enhancing NOTCH1 signaling.

Authors:  Zhengzheng Xiao; Xiaoli Yang; Zebin Liu; Zheng Shao; Chaojun Song; Kun Zhang; Xiaobin Wang; Zhengwei Li
Journal:  Mol Med Rep       Date:  2021-03-02       Impact factor: 2.952

7.  miR‑125b‑mediated regulation of cell proliferation through the Jagged‑1/Notch signaling pathway by inhibiting BRD4 expression in psoriasis.

Authors:  Min Pan; Yao Huang; Xiaofang Zhu; Xiangfei Lin; Dan Luo
Journal:  Mol Med Rep       Date:  2019-04-24       Impact factor: 2.952

8.  Long Non-Coding RNA-Based Functional Prediction Reveals Novel Targets in Notch-Upregulated Ovarian Cancer.

Authors:  Seonhyang Jeong; Sunmi Park; Young Suk Jo; Moon Jung Choi; Gibbeum Lee; Seul Gi Lee; Min Chul Choi; Hyun Park; Won Duk Joo; Sang Geun Jung; Jandee Lee
Journal:  Cancers (Basel)       Date:  2022-03-18       Impact factor: 6.639

Review 9.  Mammary Development and Breast Cancer: a Notch Perspective.

Authors:  Weizhen Chen; Wei Wei; Liya Yu; Zi Ye; Fujing Huang; Liyan Zhang; Shiqi Hu; Cheguo Cai
Journal:  J Mammary Gland Biol Neoplasia       Date:  2021-08-10       Impact factor: 2.673

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.